These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9470847)

  • 1. Metallothionein and Fas (CD95) are expressed in squamous cell carcinoma of the tongue.
    Sundelin K; Jadner M; Norberg-Spaak L; Davidsson A; Hellquist HB
    Eur J Cancer; 1997 Oct; 33(11):1860-4. PubMed ID: 9470847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallothionein expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patient survival.
    Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Sastre-Garau X
    Histopathology; 2011 Sep; 59(3):514-25. PubMed ID: 22034891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas receptor is expressed in human lung squamous cell carcinomas, whereas bcl-2 and apoptosis are not pronounced: a preliminary report.
    Hellquist HB; Olejnicka B; Jadner M; Andersson T; Sederholm C
    Br J Cancer; 1997; 76(2):175-9. PubMed ID: 9231916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ErbB2 and fatty acid synthase (FAS) expression in 102 squamous cell carcinomas of the tongue: correlation with clinical outcomes.
    Silva SD; Perez DE; Alves FA; Nishimoto IN; Pinto CA; Kowalski LP; Graner E
    Oral Oncol; 2008 May; 44(5):484-90. PubMed ID: 17825601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboplatin induces Fas (APO-1/CD95)-dependent apoptosis of human tongue carcinoma cells: sensitization for apoptosis by upregulation of FADD expression.
    Mishima K; Nariai Y; Yoshimura Y
    Int J Cancer; 2003 Jul; 105(5):593-600. PubMed ID: 12740905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of Fas (APO-1/CD95) expression in laryngeal squamous cell carcinoma.
    Jäckel MC; Mitteldorf C; Schweyer S; Füzesi L
    Head Neck; 2001 Aug; 23(8):646-52. PubMed ID: 11443747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of FasL expression in oral squamous cell cancer.
    Fang L; Sun L; Hu FF; Chen QE
    Asian Pac J Cancer Prev; 2013; 14(1):281-5. PubMed ID: 23534738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
    Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ
    Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship of apoptosis and expression of Fas gene in tongue squamous cell carcinoma cell line Tca8113].
    Huang HZ; Hou JS; Wang JG; Cheng B
    Shanghai Kou Qiang Yi Xue; 2003 Apr; 12(2):136-8. PubMed ID: 14661521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
    Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
    Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metallothionein immunoreactivity in head and neck carcinomas; special reference to clinical behaviors and chemotherapy responses.
    Muramatsu Y; Hasegawa Y; Fukano H; Ogawa T; Namuba M; Mouri K; Fujimoto Y; Matsuura H; Takai Y; Mori M
    Anticancer Res; 2000; 20(1A):257-64. PubMed ID: 10769664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of metallothionein on oral squamous cell carcinoma.
    Cardoso SV; Barbosa HM; Candellori IM; Loyola AM; Aguiar MC
    Virchows Arch; 2002 Aug; 441(2):174-8. PubMed ID: 12189508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of metallothionein expression in non-small cell lung carcinomas.
    Dziegiel P; Jeleń M; Muszczyńska B; Maciejczyk A; Szulc A; Podhorska-Okołów M; Cegielski M; Zabel M
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():43-5. PubMed ID: 15638370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia and differentiation in squamous cell carcinomas of the uterine cervix: pimonidazole and involucrin.
    Azuma Y; Chou SC; Lininger RA; Murphy BJ; Varia MA; Raleigh JA
    Clin Cancer Res; 2003 Oct; 9(13):4944-52. PubMed ID: 14581369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue.
    Xie X; Clausen OP; De Angelis P; Boysen M
    Cancer; 1999 Sep; 86(6):913-20. PubMed ID: 10491515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression pattern of cisplatin-induced metallothionein isoforms in squamous cell carcinoma.
    Nakano M; Sogawa CA; Sogawa N; Mishima K; Yamachika E; Mizukawa N; Fukunaga J; Kawamoto T; Sawaki K; Sugahara T; Furuta H
    Anticancer Res; 2003; 23(1A):299-303. PubMed ID: 12680227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of fas (CD95/APO-1) antigen induced by radiation therapy for diffuse B-cell lymphoma: immunohistochemical study.
    Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2211-6. PubMed ID: 9815617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alteration of Fas/FasL gene expression in oral squamous cell carcinoma cell line Tca83 by retinoid acid].
    Guan W; Yu S; Gao Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 May; 36(3):215-8. PubMed ID: 11812347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in squamous-cell carcinoma by interferon-gamma and cisplatin.
    Moers C; Warskulat U; Müschen M; Even J; Niederacher D; Josien R; Koldovsky U; Beckmann MW; Häussinger D
    Int J Cancer; 1999 Feb; 80(4):564-72. PubMed ID: 9935158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of Fas, Fas ligand, Fas-associated death domain protein, caspase 8 and mutant P53 protein in esophageal squamous cell carcinoma].
    Xue LY; Ren LQ; Luo W; Guan XJ; Zou SM; Zheng S; Bi R; Xie YQ; He ZG; Lü N
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):150-4. PubMed ID: 17425843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.